Opus Capital Group’s AstraZeneca AZN Stock Holding History

Opus Capital Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,553	Closed	-$293K	–	146
2019 Q2	$293K	Hold	3,553	–	–	0.09%	105
2019 Q1	$287K	Sell	3,553 -272	-7%	-$21.4K	0.08%	184
2018 Q4	$291K	Hold	3,825	–	–	0.06%	187
2018 Q3	$303K	Sell	3,825 -1,750	-31%	-$132K	0.07%	199
2018 Q2	$391K	Hold	5,575	–	–	0.1%	153
2018 Q1	$390K	Hold	5,575	–	–	0.1%	156
2017 Q4	$387K	Hold	5,575	–	–	0.09%	164
2017 Q3	$378K	Buy	5,575 +2,605	+88%	+$165K	0.09%	161
2017 Q2	$202K	Buy	+2,970	New	+$194K	0.04%	213
2016 Q1	–	Sell	-2,970	Closed	-$202K	–	194
2015 Q4	$202K	Buy	+2,970	New	+$195K	0.03%	249

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Opus Capital Group's AZN Position: Q3 2019 in Review

Opus Capital Group sold out of AstraZeneca (AZN) in Q3 2019, closing a stake of 3,553 shares — an estimated $293K sold.

Opus Capital Group first reported a position in AZN in Q4 2015 and held it in 10 quarters. The position peaked at $391K in Q2 2018. 555 funds tracked by Wall St. Rank hold AZN as of Q3 2019.

Opus Capital Group reported no remaining AstraZeneca position as of Q3 2019 after selling out during the quarter.
Opus Capital Group sold 3,553 AstraZeneca shares in Q3 2019, an estimated $293K.
Opus Capital Group first reported a position in AstraZeneca in Q4 2015 and held it in 10 quarters.
Opus Capital Group's AstraZeneca position peaked at $391K in Q2 2018.
555 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2019.

Based on Opus Capital Group's 13F filing for Q3 2019, filed 4 Nov 2019.